LEXICON PHARMACEUTICALS, INC.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Lexicon Pharmaceuticals is a biopharmaceutical company that develops drugs for diabetes, heart failure, and other metabolic and neuropathic conditions, including its approved product sotagliflozin (Inpefa) for heart failure.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Exton MichaelChief Executive Officer | Buy | $50K | 30,064at $1.66 | Nov 6, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable LXRX activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.